ATE381932T1 - Liposomale zubereitungen von indolocarbazol- derivaten - Google Patents

Liposomale zubereitungen von indolocarbazol- derivaten

Info

Publication number
ATE381932T1
ATE381932T1 AT97926234T AT97926234T ATE381932T1 AT E381932 T1 ATE381932 T1 AT E381932T1 AT 97926234 T AT97926234 T AT 97926234T AT 97926234 T AT97926234 T AT 97926234T AT E381932 T1 ATE381932 T1 AT E381932T1
Authority
AT
Austria
Prior art keywords
indolocarbazole derivatives
liposomal preparations
liposome
indolocarbazole
derivatives
Prior art date
Application number
AT97926234T
Other languages
English (en)
Inventor
Yasuki Kato
Masahiro Yamauchi
Kunio Ito
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Application granted granted Critical
Publication of ATE381932T1 publication Critical patent/ATE381932T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT97926234T 1996-06-18 1997-06-12 Liposomale zubereitungen von indolocarbazol- derivaten ATE381932T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15645996 1996-06-18

Publications (1)

Publication Number Publication Date
ATE381932T1 true ATE381932T1 (de) 2008-01-15

Family

ID=15628218

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97926234T ATE381932T1 (de) 1996-06-18 1997-06-12 Liposomale zubereitungen von indolocarbazol- derivaten

Country Status (10)

Country Link
US (1) US6045822A (de)
EP (1) EP0850646B1 (de)
AT (1) ATE381932T1 (de)
AU (1) AU718856B2 (de)
CA (1) CA2229892C (de)
DE (1) DE69738416T2 (de)
DK (1) DK0850646T3 (de)
ES (1) ES2296311T3 (de)
PT (1) PT850646E (de)
WO (1) WO1997048398A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200968B1 (en) * 1998-08-06 2001-03-13 Cephalon, Inc. Particle-forming compositions containing fused pyrrolocarbazoles
US7795246B2 (en) 1998-08-06 2010-09-14 Cephalon, Inc. Particle-forming compositions containing fused pyrrolocarbazoles
CA2376849C (en) * 1999-06-24 2008-10-14 Kyowa Hakko Kogyo Co., Ltd. Method of inhibiting leakage of drug encapsulated in liposomes
DK1347743T3 (da) * 2000-12-07 2006-07-03 Univ Utrecht Holding Bv Præparat til behandling af inflammatoriske lidelser
US7396852B2 (en) 2005-11-16 2008-07-08 Xerox Corporation Compound having indolocarbazole moiety and divalent linkage
US20060124921A1 (en) * 2004-12-14 2006-06-15 Xerox Corporation Compound with indolocarbazole moieties and devices containing such compound
TWI468188B (zh) 2008-01-30 2015-01-11 Univ Tokushima Anti-cancer effect enhancers consisting of oxaliplatin liposomal preparations and anticancer agents comprising the formulation
JP5638204B2 (ja) * 2009-05-29 2014-12-10 国立大学法人 岡山大学 経口投与用リポソーム製剤およびその製造方法
SG10201701063WA (en) 2012-08-10 2017-04-27 Taiho Pharmaceutical Co Ltd Stable oxaliplatin-encapsulating liposome aqueous dispersion and method for stabilizing same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2766360B2 (ja) * 1988-02-04 1998-06-18 協和醗酵工業株式会社 スタウロスポリン誘導体
US4952567A (en) * 1988-05-09 1990-08-28 City Of Hope Inhibition of lipogenesis
JP2694701B2 (ja) * 1989-08-24 1997-12-24 日本油脂株式会社 液体膜制癌剤
IL100833A0 (en) * 1991-02-20 1992-09-06 Greenwich Pharma Method for synthesis of ethereally substituted blocked monosaccharides
JPH07278016A (ja) * 1994-04-13 1995-10-24 Pola Chem Ind Inc 抗癌剤リポソーム製剤
EP0711557A1 (de) * 1994-11-09 1996-05-15 Ciba-Geigy Ag Pharmazeutische Formulierungsgrundlage

Also Published As

Publication number Publication date
WO1997048398A1 (fr) 1997-12-24
PT850646E (pt) 2008-03-31
CA2229892C (en) 2003-01-07
AU3106697A (en) 1998-01-07
EP0850646B1 (de) 2007-12-26
EP0850646A1 (de) 1998-07-01
CA2229892A1 (en) 1997-12-24
DE69738416T2 (de) 2008-12-11
EP0850646A4 (de) 2005-06-22
DE69738416D1 (de) 2008-02-07
US6045822A (en) 2000-04-04
ES2296311T3 (es) 2008-04-16
DK0850646T3 (da) 2008-05-13
AU718856B2 (en) 2000-04-20

Similar Documents

Publication Publication Date Title
NZ278072A (en) Phenylacetic acid oxime derivatives; biocides
MX9301457A (es) Agentes antifungicos de peptidos ciclicos y proceso para su preparacion.
DK0582788T3 (da) 7-(Substituerede)-9-[(substitueret glycyl)-amido]-demethyl-6-deoxytetracycliner
HN1998000036A (es) Compuesto de pirazina
ATE263771T1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
DE69511424D1 (de) Antifungale sordaridinderivate
ATE381932T1 (de) Liposomale zubereitungen von indolocarbazol- derivaten
DE69621469D1 (de) Phenylpiperidin-derivate
ATE172463T1 (de) Pyrrolocarbazol
AU1634388A (en) Cyclic anticoagulant peptides
AU1634288A (en) Cyclic anticoagulant peptides
AU626070B2 (en) Anticoagulant peptide alcohols
FI952420A (fi) Glukopyranosidibentsotiofeenit
FI901277A0 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ.
FI95602C (fi) Menetelmä deoksimulundokandiinin valmistamiseksi
TH44959A (th) อนุพันธ์รีซอร์ซินอล

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0850646

Country of ref document: EP

REN Ceased due to non-payment of the annual fee